These specific blood tests detect the presence of autoantibodies targeting cellular components often involved in systemic autoimmune rheumatic diseases. Positive findings can indicate conditions such as Sjgren’s syndrome, systemic lupus erythematosus (SLE), and other connective tissue disorders. For example, a patient experiencing dry eyes and mouth might undergo this testing to aid in diagnosis.
Evaluating these autoantibodies provides crucial diagnostic information for rheumatologists and other healthcare professionals. Their presence, combined with clinical symptoms and other laboratory findings, helps differentiate between various autoimmune conditions and guides treatment strategies. Historically, identifying these markers represented a significant advancement in understanding and managing these complex illnesses.